BRCOQ yields 2000000.00% · JNJ yields 2.13%● Live data
📍 BRCOQ pulled ahead of the other in Year 1
Combined, BRCOQ + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BRCOQ + JNJ for your $10,000?
The Beard Company, through its subsidiaries, engages in carbon dioxide, oil and gas, coal reclamation, and e-commerce businesses in the United States. The company's Carbon Dioxide segment produces and sells carbon dioxide gas in Colorado and New Mexico. Its Oil and Gas segment engages in the exploration, development, production, and sale of oil and gas. This segment owns non-operated working interests or overriding royalty interests in producing wells in Colorado and Wyoming; and undeveloped oil and gas leases in such states and in Mississippi. The company's Coal Reclamation segment operates coal fines reclamation facilities; and provides slurry pond core drilling services, fine coal laboratory analytical services, and consulting services. Its e-Commerce segment holds Voucher patent that is offered under royalty basis. The company was founded in 1921 and is headquartered in Oklahoma City, Oklahoma. On October 12, 2012, The Beard Company, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Western District of Oklahoma. Beard Co. is in liquidation.
Full BRCOQ Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.